Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.
about
Adenovirus vectors for gene therapy, vaccination and cancer gene therapyFiber mediated receptor masking in non-infected bystander cells restricts adenovirus cell killing effect but promotes adenovirus host co-existenceGlucocorticoid receptor over-expression promotes human small cell lung cancer apoptosis in vivo and thereby slows tumor growth.A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancerA new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: the safety profile of ad5/3-Δ24 in advance of a phase I clinical trial in ovarian cancer patients.Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathwayAdenoviral insulinoma-associated protein 1 promoter-driven suicide gene therapy with enhanced selectivity for treatment of neuroendocrine cancers.Armed replicating adenoviruses for cancer virotherapy.Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery.Interaction of adenovirus type 5 fiber with the coxsackievirus and adenovirus receptor activates inflammatory response in human respiratory cells.
P2860
Q27001601-88F1B1AE-2F53-4D47-82CD-A94C990AF698Q33521271-60BDFF3A-A963-4E27-9897-373619A02DB4Q33689201-8BC602DC-C98D-4B89-AE5F-4104D97ABC42Q33786353-0C1F77DD-1DD7-4055-A36A-E87DF984B5B0Q35101968-948E71E5-144D-4531-8BB9-95D7BFE8BF9FQ36205238-C1966330-A3AC-43F0-A5B1-5C34DE65F15AQ36398900-B5B3C5F1-D993-4998-A6A8-2CF7A80AC65DQ36701589-A91C6B55-A5EA-44BB-8AFC-2881EDA3D6C8Q37386616-7C3F9092-B1A7-4E66-BF51-FB0DFE21966AQ38308865-CFFCB100-F147-4B58-B1E9-C473873A4654Q39305849-2189CE5B-482C-417D-962F-2DD2F8B8980B
P2860
Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Advanced generation adenoviral ...... ndent cellular entry capacity.
@ast
Advanced generation adenoviral ...... ndent cellular entry capacity.
@en
Advanced generation adenoviral ...... ndent cellular entry capacity.
@nl
type
label
Advanced generation adenoviral ...... ndent cellular entry capacity.
@ast
Advanced generation adenoviral ...... ndent cellular entry capacity.
@en
Advanced generation adenoviral ...... ndent cellular entry capacity.
@nl
prefLabel
Advanced generation adenoviral ...... ndent cellular entry capacity.
@ast
Advanced generation adenoviral ...... ndent cellular entry capacity.
@en
Advanced generation adenoviral ...... ndent cellular entry capacity.
@nl
P2093
P1433
P1476
Advanced generation adenoviral ...... ndent cellular entry capacity.
@en
P2093
Belousova N
Dmitriev I
Douglas JT
Kashentseva E
Krasnykh V
Navarro JG
P304
P407
P577
2000-12-01T00:00:00Z